✦ LIBER ✦

A phase II trial of the oral mTOR inhibitor everolimus in relapsed aggressive lymphoma

✍ Scribed by Witzig, T E; Reeder, C B; LaPlant, B R; Gupta, M; Johnston, P B; Micallef, I N; Porrata, L F; Ansell, S M; Colgan, J P; Jacobsen, E D

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase II trial of the oral mTOR inhibi

✍ Patrick B. Johnston; David J. Inwards; Joseph P. Colgan; Betsy R. Laplant; Brian 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 217 KB

A phase I clinical trial of the mTOR inh

✍ M. Abu-Khalaf; A. Santin; E. Ratner; D. Silasi; K. ElSahwi; L. Baker; M. Luther; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 111 KB

Phase I study of the oral mammalian targ

✍ Kensei Tobinai; Michinori Ogura; Dai Maruyama; Toshiki Uchida; Naokuni Uike; Ils 📂 Article 📅 2010 🏛 Carden Jennings Publishing 🌐 English ⚖ 345 KB

6003 ORAL Phase II trial of oral vorinos

✍ Crump, M.; Coiffier, B.; Jacobsen, E.D.; Sun, L.; Ricker, J.L.; Xie, H.; Frankel 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Phase I and pharmacokinetic study of cap

✍ Maarten J. Deenen, Heinz-Josef Klümpen, Dick J. Richel, Rolf W. Sparidans, Marie 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 299 KB

Oral lenalidomide with rituximab in rela

✍ Wang, M; Fowler, N; Wagner-Bartak, N; Feng, L; Romaguera, J; Neelapu, S S; Hagem 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 817 KB